This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That The Merger May Not Be In The Best Interest Of Investors Of Questcor Pharmaceuticals, Inc. - QCOR

NEW YORK, April 7, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (NASDAQ: QCOR) (ISIN: US74835Y1010) (CUSIP: 74835Y101) concerning the proposed acquisition of Questcor by Mallinckrodt Plc.        

The investigation concerns whether the Questcor directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value.  Under the terms of the transaction, Questcor shareholders will receive $86.08 in a combination of cash and stock for each share of Questcor common stock owned.  However, the Price to EBITDA and Revenue multiples are below the averages of comparable transactions.  Additionally, at least one analyst has set a target price of $99.00 per share for Questcor common stock.

Questcor shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at or 212-661-1100 or 888-476-6529, ext. 237.

Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See

CONTACT: Robert WilloughbyPomerantz LLP212-661-1100 ext. 237

SOURCE Pomerantz LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,085.59 -46.27 -0.27%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,810.7640 -27.8790 -0.58%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs